CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 7147-7153

  Ji, Jiaxiang ^a   Masterson, Joseph ^a   Sun, Jiaren ^a   Soong, Lynn ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LEISHMANIA; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMASTIGOTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; SPLEEN CELL; STRAIN DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 18944370310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.7147     Document Type: Article

References (53)

1. Neva, F., and D. Sacks. 1990. Leishmaniasis. In Trop Geographic Med. K. S. Warren and A. A. S. Mahmoud, eds. McGraw-Hill, New York, p. 296-308.
2. Almeida, R. P., M. Barral-Netto, A. M. R. de Jesus, L. A. R. de Freitas, E. M. Carvalho, and A. Barral. 1996. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice. Am. J. Trop. Med. Hyg. 54: 178-184.
3. Berman, J. D. 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev. Infect. Dis. 10: 560-586.
4. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158: 5374-5383.
5. Jones, D. E., L. U. Buxbaum, and P. Scott. 2000. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165: 364-372.
6. Ji, J., J. Sun, H. Qi, and L. Soong. 2002. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66: 338-345.
7. Ji, J., J. Sun, and L. Soong. 2003. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71: 4278-4288.
8. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191: 1063-1068.
9. Mosser, D. M., and C. L. Karp. 1999. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11: 406-411.
10. Grazia Cappiello, M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation. J. Immunol. 166: 4498-4506.
11. Gerber, J. S., and D. M. Mosser. 2001. Stimulatory and inhibitory signals originating from the macrophage Fc-γ receptors. Microbes Infect. 3: 131-139.
12. Prina, E., S. Z. Abdi, M. Lebastard, E. Perret, N. Winter, and J. C. Antoine. 2004. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J. Cell Sci. 117: 315-325.
13. Afonso, L. C. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61: 2952-2959.
14. Soong, L., J.-C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273.
15. + T cells in vivo. J. Immunol. 167: 4534-4542.
16. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261: 1448-1451.
17. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162: 6132-6140.
18. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
19. Bach, J. F., and J. Francois Bach. 2003. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3: 189-198.
20. Sakaguchi, S. 2003. Regulatory T cells: mediating compromises between host and parasite. Nat. Immunol. 4: 10-11.
21. + regulatory T cells. Trends Immunol. 25: 374-380.
22. Greenwald, R. J., V. A. Boussiotis, R. B. Lorsbach, A. K. Abbas, and A. H. Sharpe. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14: 145-155.
23. + T cells in graft-versus-host disease. J. Exp. Med. 200: 149-157.
24. Zheng, Y., C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172: 2778-2784.
25. + regulatory T cells. Nat. Immunol. 4: 330-336.
26. Ramsdell, F. 2003. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165-168.
27. Raghavan, S., E. Suri-Payer, and J. Holmgren. 2004. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Scand. J. Immunol. 60: 82-88.
28. + regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol. 132: 393-400.
29. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32: 1282-1291.
30. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
31. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells. Leishmania major infection, and colitis in mice. J. Immunol. 170: 394-399.
32. + regulatory T cells in Leishmania infection. Expert Opin. Biol. Ther. 3: 875-885.
33. + T cells. J. Immunol. 169: 3232-3241.
34. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29: 762-773.
35. Qi, H., J. Ji, N. Wanasen, and L. Soong. 2004. Enhanced replication of Leishmania amazonensis amastigotes in γ interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect. Immun. 72: 988-995.
36. Rouse, B. T., and S. Suvas. 2004. Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol. 173: 2211-2215.
37. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200: 201-210.
38. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
39. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
40. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164: 183-190.
41. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165: 969-977.
42. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151-177.
43. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol 1: 845-858.
44. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171: 5012-5017.
45. McMahon-Pratt, D., and J. Alexander. 2004. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev. 201: 206-224.
46. Harms, G., K. Zwingenberger, A. K. Chehade, S. Talhari, P. Racz, A. Mouakeh, M. Douba, L. Nakel, R. D. Naiff, P. G. Kremsner, et al. 1989. Effects of intradermal γinterferon in cutaneous leishmaniasis. Lancet 1: 1287-1292.
47. Colmenares, M., S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt. 2002. Mechanisms of pathogenesis: differences amongst Leishmania species. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1): S3-S7.
48. Guevara-Mendoza, O., C. Une, P. Fanceschi Carreira, and A. Orn. 1997. Experimental infection of BALB/c mice with Leishmania panamensis and Leishmania mexinana: induction of early IFN-γ but not IL-4 is associated with the development of cutaneous lesions. Scand. J. Immunol. 46: 35-40.
49. Qi, H. 2003. Parasite interactions with dendritic cells and macrophages: implications for leishmaniasis caused by Leishmania amazonensis. Doctoral dissertation, University of Texas Medical Branch, Galveston, TX.
50. Norsworthy, N. B., J. Sun, D. Elnaiem, G. Lanzaro, and L. Soong. 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72: 1240-1247.
51. Paust, S., L. Lu, N. McCarty, and H. Cantor. 2004. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101: 10398-10403.
52. Taylor, P. A., C. J. Lees, S. Founder, J. P. Allison, A. H. Sharpe, and B. R. Blazar. 2004. B7 expression on T cells down-regulates immune responses through CTLA-4 Iigation via T-T interactions. J. Immunol. 172: 34-39.
53. Sacks, D., and C. Anderson. 2004. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201: 225-238.